483
Adam M. Sun, M.DFDA 483 - Adam M. Sun, M.D - February 25, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Adam M. Sun, M.D. in Rosemead, CA, was cited for significant deficiencies in clinical trial conduct during an FDA inspection. Observations included failures to conduct investigations according to protocol, delayed reporting of adverse events to the sponsor, inadequate investigational drug disposition records, and inaccurate case histories. These issues indicate a lack of adherence to regulatory requirements for clinical investigations.
Open in Dashboard
ID · ca6f7236-b607-4025-956f-fc3d9c44ad41